IN RE CYCLOBENZAPRINE HYDROCHLORIDE

Civ. No. 09-2118-SLR.

794 F.Supp.2d 517 (2011)

In re CYCLOBENZAPRINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULE PATENT LITIGATION.

United States District Court, D. Delaware.

May 12, 2011.


Attorney(s) appearing for the Case

William J. Marsden, Jr., Esquire , Susan M. Coletti, Esquire , and Jennifer L. Hall, Esquire , of Fish & Richardson P.C., Wilmington, DE, of Counsel: John D. Garretson, Esquire , and John S. Goetz, Esquire of Fish & Richardson P.C., New York, NY, Jonathan E. Singer, Esquire and Geoff D. Biegler, Esquire of Fish & Richardson P.C., Minneapolis, MN, Juanita Brooks, Esquire of Fish & Richardson P.C., San Diego, CA, for Plaintiffs Eurand, Inc, Cephalon, Inc., and Anesta AG.

Tryn T. Stimart, Esquire of Cooley LLP, Washington, D.C., Jon Graves, Esquire , of Cooley LLP, Reston, VA, Of Counsel for plaintiff Eurand, Inc.

John C. Phillips, Jr., Esquire of Phillips Goldman & Spence, P.A., Wilmington, DE, of Counsel: George C. Lombardi, Esquire , Maureen L. Ruka, Esquire , Lynn M. Ulrich, Esquire , and Julia M. Johnson, Esquire of Winston & Strawn LLP, Chicago, IL, Megan C. Haney, Esquire of Phillips, Goldman & Spence, P.A., Wilmington, DE, for Defendants Barr Laboratories, Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.

Richard L. Horwitz, Esquire and David E. Moore, Esquire , of Potter, Anderson and Corroon LLP, Wilmington, DE, of Counsel: James H. Wallace Jr., Esquire , Mark A. Pacella, Esquire , Robert J. Scheffel, Esquire , Brian H. Pandya, Esquire , and Matthew J. Dowd, Esquire of Wiley Rein LLP, Washington, D.C., for Defendants Mylan Inc. and Mylan Pharmaceuticals, Inc.


OPINION

SUE L. ROBINSON, District Judge.

I. INTRODUCTION

This action arises out of the filing of an Abbreviated New Drug Application ("ANDA")1 by Mylan Pharmaceuticals, Inc. ("Mylan"), Barr Laboratories, Inc. ("Barr"), Impax Laboratories, Inc. ("Impax") and Anchen Pharmaceuticals, Inc. ("Anchen") to market a generic version of the pain drug AMRIX® proprietary to Eurand, Inc ("Eurand") and exclusive licensee Anesta...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases